Evidence map›Paper›PMID 24367243›Full record

Trial reportTheScientificWorldJournal2013

Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients.

Vincenzo Panichi, Enrico Fiaccadori, Alberto Rosati, Roberto Fanelli, Giada Bernabini, Alessia Scatena, Francesco Pizzarelli

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in TheScientificWorldJournal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2023
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Vincenzo PanichiNephrology and Dialysis Unit, Versilia Hospital, 55034 Lido Camaiore (Lucca), Italy.
Enrico FiaccadoriNephrology and Dialysis Unit, Parma Hospital, 43100 Parma, Italy.
Alberto RosatiNephrology and Dialysis Unit, Lucca Hospital, 55100 Lucca, Italy.
Roberto FanelliNephrology and Dialysis Unit, SM Annunziata Hospital, 50012 Florence, Italy.
Giada BernabiniNephrology and Dialysis Unit, Versilia Hospital, 55034 Lido Camaiore (Lucca), Italy.
Alessia ScatenaNephrology and Dialysis Unit, Versilia Hospital, 55034 Lido Camaiore (Lucca), Italy.
Francesco PizzarelliNephrology and Dialysis Unit, SM Annunziata Hospital, 50012 Florence, Italy.
Ospedale Versilia · ITOspedale SS. Annunziata · ITIMT School for Advanced Studies Lucca · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCitrate has anticoagulative properties and favorable effects on inflammation, but it has the potential hazards of inducing hypocalcemia. Bicarbonate dialysate (BHD) replacing citrate for acetate is now used in chronic haemodialysis but has never been tested in postdilution online haemodiafiltration (OL-HDF).

methodsThirteen chronic stable dialysis patients were enrolled in a pilot, short-term study. Patients underwent one week (3 dialysis sessions) of BHD with 0.8 mmol/L citrate dialysate, followed by one week of postdilution high volume OL-HDF with standard bicarbonate dialysate, and one week of high volume OL-HDF with 0.8 mmol/L citrate dialysate.

resultsIn citrate OL-HDF pretreatment plasma levels of C-reactive protein and β 2-microglobulin were significantly reduced; intra-treatment plasma acetate levels increased in the former technique and decreased in the latter. During both citrate techniques (OL-HDF and HD) ionized calcium levels remained stable within the normal range.

conclusionsShould our promising results be confirmed in a long-term study on a wider population, then OL-HDF with citrate dialysate may represent a further step in improving dialysis biocompatibility.

Indexed as

AdultAgedAnticoagulantsCitric AcidDialysis SolutionsFeasibility StudiesFemaleHemodiafiltrationHemodilutionHumansItalyKidney Failure, ChronicMaleMiddle AgedPilot ProjectsSodium BicarbonateAnticoagulantsCitric AcidDialysis SolutionsSodium Bicarbonate

Identifiers

PMID24367243
PMCPMC3866782
OpenAlexW2038016273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.